Literature DB >> 16798819

Passive pericardial constraint protects against stretch-induced vulnerability to atrial fibrillation in rabbits.

Daniel M Ninio1, David A Saint.   

Abstract

Atrial fibrillation is more common in conditions with elevated atrial pressure and can be induced experimentally with acute increases in atrial pressure. We examined the effect of increased atrial pressure with and without pericardial constraint to better separate the effects of increased pressure and atrial stretch. In Langendorff-perfused rabbit hearts with intact pericardium, after ligating the pulmonary and caval veins, intra-atrial pressures were increased in a stepwise manner by adjusting the pulmonary outflow cannula. Rapid burst pacing was applied to induce atrial fibrillation at increasing intra-atrial pressures from 0 to 24 cmH(2)O. The atrial refractory period was recorded at each pressure using a single extra stimulus. The protocol was repeated after the pericardium was removed. When the pericardium was intact, atrial stretch was limited by passive constraint, and sustained atrial fibrillation could not be induced despite atrial pressures in excess of 20 cmH(2)O. In contrast, when the pericardium was removed, atrial fibrillation could be reliably induced when atrial pressure exceeded 15 cmH(2)O. This suggests that the electrophysiological effects of acute atrial volume loading rely on atrial stretch rather than increased atrial pressure alone.

Entities:  

Mesh:

Year:  2006        PMID: 16798819     DOI: 10.1152/ajpheart.01248.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  2 in total

1.  Gold nanoparticle-spermidine complex blocks the inward rectifier potassium channel.

Authors:  Chur Chin
Journal:  Am J Cardiovasc Dis       Date:  2014-06-28

Review 2.  Rabbit models of cardiac mechano-electric and mechano-mechanical coupling.

Authors:  T Alexander Quinn; Peter Kohl
Journal:  Prog Biophys Mol Biol       Date:  2016-05-18       Impact factor: 3.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.